Will a company publicly announce that a new mRNA-based treatment has met its primary endpoint(s) in a Phase 1 or Phase 2 human trial between May 1 and June 30, 2026?

Will a company publicly announce that a new mRNA-based treatment has met its primary endpoint(s) in a Phase 1 or Phase 2 human trial between May 1 and June 30, 2026? | Prophecy